To further investigate the relationship between the TP53 gene expression signature and drug sensitivity at the cell level, we analyzed p53 deficiency and paclitaxel sensitivity by an actual cell culture model of breast cancer where a strong inverse association between p53 deficiency and paclitaxel sensitivity was observed (Fig. 2B). This evidence concerns the gene TP53 and breast cancer.